Dr. Daniel Bateman on Brain CareNotes

Daniel Bateman, M.D., receives federal award to study technological intervention

A Regenstrief Institute research scientist is testing a novel mobile app designed to improve care for people with Alzheimer’s disease. Daniel Bateman, M.D., has received a career development award from the National Institute on Aging to test the feasibility and usability of the revised Brain CareNotes app.

Approximately 97% of people with dementia experience behavioral and psychological symptoms of dementia (BPSD) during the course of their illness. Those symptoms can include depression, anxiety, hallucinations, agitation, apathy, and many more. These conditions can cause many problems for people with dementia and for their caregivers, including a higher death rate, greater use of the emergency department, earlier placement in a nursing home and greater burden on caregivers.

Dr. Bateman, a geriatric psychiatrist, hopes the Brain CareNotes app will help ease some of those problems. “These symptoms cause real struggles for patients and the people who are working to care for them,” said Dr. Bateman, a research scientist at the Indiana University Center for Aging Research at Regenstrief Institute. “We hope this app will help manage these symptoms and improve quality of life for patients and caregivers.”

The Brain CareNotes app was designed by Regenstrief researchers, including Dr. Bateman, Richard Holden, PhD, and Malaz Boustani, M.D., in partnership with the Sandra Eskenazi Center for Brain Care Innovation staff, including Catherine Alder, JD, and with Youngbok Hong, MFA, and Aaron Ganci, MFA, who are faculty at the Herron School of Art and Design at IUPUI. The development team conducted multiple focus groups, interviews and user tests with clinicians and caregivers to create the user-centered app.

In Dr. Bateman’s new study, patient-caregiver pairs from the Healthy Aging Brain Center at Eskenazi Health will be randomly put into two groups. One will receive usual care provided by the center, which involves an interdisciplinary team of providers. The other group will use the Brain CareNotes app in addition to receiving usual care from the team.

In the group using the app, caregivers will receive prompts on their phone to fill out a symptom questionnaire. If the answers reach a designated threshold of concern, the patient’s care providers will be notified and will follow up through a phone call, a message, or another form of communication.

The goal of this study is to determine if it is practical and tolerable for caregivers to complete the questionnaire, as well as to assess whether completing the survey document leads to improved care and health. Researchers will also evaluate if the app changed the behavior of the clinicians.

“Healthcare is moving mobile,” continued Dr. Bateman. “There are never going to be enough providers to manage the number of people with Alzheimer’s disease and dementia, which is only going to increase. We hope the Brain CareNotes app will maximize each geriatrics care worker’s ability to make an impact and improve care.”

Dr. Bateman and his team hope that if this trial is successful, the Brain CareNotes app will eventually be used to improve care across the country and around the world.

This five-year study has been titled MOMENT: (MObile AssessMENT of Behavioral and Psychological Symptoms of Dementia in Adults with Alzheimer’s Disease.) Christopher Callahan, M.D., a research scientist in the IU Center for Aging Research at Regenstrief is collaborating with Dr. Bateman on MOMENT. Dr. Callahan also oversees the activities of the Sandra Eskenazi Center for Brain Care Innovation.

Brain CareNotes is also the subject of another NIA randomized controlled trial, called I-CARE, led by Dr. Holden and Dr. Boustani. You can learn more about the Brain CareNotes app here.

In addition to his role at Regenstrief, Dr. Bateman is an implementation scientist with the Center for Health Innovation and Implementation Science and an assistant professor of psychiatry at Indiana University School of Medicine.

The NIA is an institute of the National Institutes of Health. The NIA leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Dec 11, 2019 • News
Algorithmovigilance: Regenstrief experts lead discussion on monitoring AI in healthcare
Four Regenstrief research scientists and leaders provided insight into the need to monitor the use of artificial intelligence algorithms in healthcare at the American Medical Informatics Association’s Health Informatics Policy Forum. The forum considered the future of clinical decision support in the era of big data and machine learning.  Regenstrief leaders President and Chief Executive…
Continue Reading >
Dec 10, 2019 • News
Putting the I in AI: Moving from ideas to implementation
Regenstrief Institute hosts forum on implementing AI in healthcare Regenstrief Institute hosted researchers, clinicians and members of the business community to discuss ideas and challenges to implement artificial intelligence in healthcare practice. The Regenstrief Entrepreneurial Ecosystem Forum featured experts from three of Regenstrief’s industry partners, Roche, Medial EarlySign and Ventech Solutions. A representative from each…
Continue Reading >